🇺🇸 Ketamine [Ketalar] in United States

2 US adverse-event reports

Marketing authorisation

FDA

• Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 2

Most-reported reactions

1. Staphylococcal Sepsis — 1 report (50%)
2. Tachycardia — 1 report (50%)

Source database →

Frequently asked questions

Is Ketamine [Ketalar] approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ketamine [Ketalar] in United States?

Medical University of Warsaw is the originator. The local marketing authorisation holder may differ — check the official source linked above.